Simultaneous integrated boost intensity‐modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open‐label, randomized, phase III clinical trial

Documenti analoghi

• The significance of consolidation chemotherapy after concurrent chemoradiotherapy in esophageal squamous cell carcinoma: a randomized controlled phase III clinical trial
  di: Qingshan Zhu, et al.
  Pubblicazione: (2024)
• Efficacy of combined radiotherapy and chemotherapy versus radiotherapy for oral squamous cell carcinoma
  di: Jaime Irisarri Arévalo
  Pubblicazione: (2015)
• Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
  di: Canjun Li, et al.
  Pubblicazione: (2025)
• Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial
  di: Ling‐Long Tang, et al.
  Pubblicazione: (2025)
• Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
  di: Lin Lu, et al.
  Pubblicazione: (2025)